![]() |
市场调查报告书
商品编码
1933319
全球机器人辅助手术人工智慧(AI)市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析以及未来预测(2026-2034)AI in Robot-Assisted Surgery Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
由于技术进步、基于人工智慧的手术解决方案的日益普及以及对精准微创手术需求的不断增长,全球机器人辅助手术人工智慧(AI)市场正在快速扩张。预计该市场将从2025年的73.2亿美元成长到2026年的104.6亿美元,到2034年将达到2047.1亿美元,预测期内复合年增长率高达45.03%。
人工智慧技术正被整合到机器人手术系统中,以帮助外科医生更精准、高效、安全地完成复杂的手术。 应用程式包括分析 CT 和 MRI 扫描以建立患者专属的 3D 模型、切口规划、植入物位置优化以及即时手术路径引导。人工智慧还能稳定机械手臂、纠正手部震颤并自动执行缝合等重复性任务,进而帮助减轻外科医师的疲劳并改善患者的治疗效果。
主要市场领导者包括 Intuitive Surgical, Inc.、Medtronic, Inc.、Zimmer Biomet Holdings, Inc. 和 Globus Medical, Inc.。这些公司透过广泛的产品组合、创新产品的推出以及策略性的地理扩张来维持其市场主导地位。
市场动态
市场驱动因素
该市场的主要驱动力是人工智慧技术的进步,它为机器人手术带来了适应性、精确性和效率。人工智慧系统可以从海量的手术资料集中学习,动态应对意外併发症,并为外科医生提供即时决策支援。
例如,2025年7月,约翰霍普金斯大学的研究人员报告称,一台经过实际手术视讯训练的手术机器人能够自主完成胆囊切除术的关键步骤,展现出更高的适应性和手术精度。
市场限制因子
高昂的资本和营运成本仍然是重要的限制因素。先进机器人系统(例如达文西手术系统)的购买成本在50万美元到250万美元之间,而年度服务费和每次手术所需的器械成本进一步限制了其普及,尤其是在新兴经济体。
市场机会
对人工智慧整合机器人手术的投资不断增加,为创新创造了机会。例如,2025年6月,ForSight Robotics公司筹集了1.25亿美元,用于开发其用于眼科手术的ORYOM平台,旨在提高手术精度、改善患者预后并提升外科医生效率。此类投资正在推动市场扩张和技术进步。
市场挑战
医疗器材和手术机器人的严格监管环境带来了许多挑战。品质系统合规、设备报告和安全验证需要投入大量资源,这可能会延迟产品批准。 2024年8月,美国FDA向Globus Medical发出警告,指出其未能满足设备通报要求,凸显了企业面临的监管障碍。
市场趋势
一个关键趋势是将基于云端的外科培训和机器学习模型相结合,从而实现外科教育和绩效评估的标准化。基于人工智慧的模型提供个人化回馈并推荐最佳实践,有助于提升医疗机构的技能水准。 2023年2月,Ascensus Surgical与Google云端合作,利用集中式资料分析增强其 "绩效导向手术" 框架,进而改善训练效果。 此外,人工智慧正越来越多地被用于自动化缝合和组织分割等精细操作,同时仍能确保外科医生完全掌控手术过程。
依产品/服务分类:
依专科分类:
依最终使用者划分:
The global AI in robot-assisted surgery market is witnessing rapid expansion due to technological advancements, increasing adoption of AI-based surgical solutions, and rising demand for precise and minimally invasive procedures. The market was valued at USD 7.32 billion in 2025, projected to grow to USD 10.46 billion in 2026, and is expected to reach USD 204.71 billion by 2034, registering a remarkable CAGR of 45.03% over the forecast period.
AI technologies are being integrated into robotic surgical systems to assist surgeons in performing complex procedures with enhanced precision, efficiency, and safety. Applications include analyzing CT and MRI scans to create patient-specific 3D models, planning incision sites, optimizing implant positioning, and guiding surgical pathways in real time. AI also stabilizes robotic arms, cancels hand tremors, and automates repetitive tasks such as suturing, reducing surgeon fatigue and improving outcomes.
Major players leading the market include Intuitive Surgical, Inc., Medtronic plc, Zimmer Biomet Holdings, Inc., and Globus Medical, Inc., with broad product portfolios, innovative launches, and strategic geographic expansion supporting their dominance.
Market Dynamics
Market Drivers
The market is primarily driven by advancing AI capabilities, offering adaptability, precision, and efficiency in robotic surgeries. AI-enabled systems can learn from vast surgical datasets, adjust dynamically to unexpected complications, and provide real-time decision support to surgeons.
For instance, in July 2025, researchers at Johns Hopkins University reported that a surgical robot trained on real procedure videos performed a critical phase of gallbladder removal autonomously, demonstrating enhanced adaptability and surgical precision.
Market Restraints
High capital and operating costs remain significant restraints. Acquisition costs for advanced robotic systems, such as the da Vinci, range from USD 0.5 million to USD 2.5 million, with annual service fees and procedure-specific instrument costs further limiting adoption, especially in emerging economies.
Market Opportunities
Growing investment in AI-integrated robotic surgeries offers opportunities for innovation. For example, in June 2025, ForSight Robotics secured USD 125 million to develop the ORYOM platform for eye surgeries, enhancing precision, patient outcomes, and surgeon efficiency. Such investments drive market expansion and technological evolution.
Market Challenges
The stringent regulatory landscape for medical devices and surgical robotics poses challenges. Compliance with quality systems, device reporting, and safety validation requires substantial resources and can delay product approvals. In August 2024, the U.S. FDA issued a warning to Globus Medical for failing to meet device reporting requirements, highlighting the regulatory hurdles faced by companies.
Market Trends
A key trend is the integration of cloud-based surgical training and machine learning models, which standardizes surgical education and performance assessment. AI-based models provide personalized feedback, highlight best practices, and improve skill development across institutions. In February 2023, Asensus Surgical, Inc. collaborated with Google Cloud to enhance its Performance-Guided Surgery framework, utilizing centralized data analytics for improved training outcomes. Additionally, AI is increasingly used to automate micro-tasks like suturing and tissue segmentation, while surgeons retain full control.
By Product & Services:
By Specialty:
By End-User:
Competitive Landscape
The market is semi-concentrated, with key players such as Intuitive Surgical, Medtronic, Zimmer Biomet, Stryker, Smith & Nephew, Globus Medical, Siemens Healthineers, Asensus Surgical, CMR Surgical, and Virtuoso Surgical. These companies focus on innovation, strategic partnerships, and geographic expansion.
Key Developments:
Conclusion
The global AI in robot-assisted surgery market is projected to grow from USD 7.32 billion in 2025 to USD 204.71 billion by 2034, at a CAGR of 45.03%. Growth is driven by increasing adoption of AI for precise, efficient, and safe surgeries, investments in innovation, and integration of cloud-based training systems. Despite high costs and stringent regulatory challenges, AI-enabled robotic surgeries are poised to transform surgical care, improve patient outcomes, and set new standards for minimally invasive procedures globally.
Segmentation By Product & Services
By Specialty
By End User
By Geography